Differential Inhibition of Human Nav1.2 Resurgent and Persistent Sodium Currents by Cannabidiol and GS967

International Journal of Molecular Sciences

TheodoreR. Cummins¹  EmilyR. Mason² 

[1] Department of Biology, Purdue School of Science, IUPUI campus, Indianapolis, IN 46202, USA;Department of Pharmacology and Toxicology, Indiana University School of Medicine, IUPUI campus, Indianapolis, IN 46202, USA;

关键词: voltage-gated sodium channels;    antiepileptic drugs;    Nav1.2;    CBD;    cannabidiol;    GS967;   

DOI  :  10.3390/ijms21072454

来源: DOAJ

【 摘 要 】

Many epilepsy patients are refractory to conventional antiepileptic drugs. Resurgent and persistent currents can be enhanced by epilepsy mutations in the Nav1.2 channel, but conventional antiepileptic drugs inhibit normal transient currents through these channels, along with aberrant resurgent and persistent currents that are enhanced by Nav1.2 epilepsy mutations. Pharmacotherapies that specifically target aberrant resurgent and/or persistent currents would likely have fewer unwanted side effects and be effective in many patients with refractory epilepsy. This study investigated the effects of cannbidiol (CBD) and GS967 (each at 1 μM) on transient, resurgent, and persistent currents in human embryonic kidney (HEK) cells stably expressing wild-type hNav1.2 channels. We found that CBD preferentially inhibits resurgent currents over transient currents in this paradigm; and that GS967 preferentially inhibits persistent currents over transient currents. Therefore, CBD and GS967 may represent a new class of more targeted and effective antiepileptic drugs.

【 授权许可】

Unknown